{
    "nctId": "NCT01064349",
    "briefTitle": "Breast Cancer With Over-expression of erbB2-BRAINSTORM",
    "officialTitle": "Breast Cancer With Over-expression of erbB2 Study of the Treatment Paradigm in Metastasis to BRAIN (BRAINSTORM)",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 144,
    "primaryOutcomeMeasure": "To describe the treatment pattern of brain metastasis in ErbB2 over-expressing breast cancer in Asia Pacific countries.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients diagnosed with erbB2+ breast cancer. ErbB2 positivity will be as determined by respective institutional standards, and will be based on medical history only.\n2. Brain metastasis diagnosis made between January 2006 - December 2008.\n\nExclusion Criteria:\n\n1. Women who have another primary cancer diagnosed between the time of breast cancer diagnosis and brain metastasis..\n2. Patient has leptomeningeal metastases only without parenchymal brain involvement (since this pattern of the disease requires a different treatment approach.)",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}